This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stapleton, J. T.
Right arrow Articles by Alden, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stapleton, J. T.
Right arrow Articles by Alden, B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 1999, p. 484-489, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Prospective Comparison of Whole-Blood- and Plasma-Based Hepatitis C Virus RNA Detection Systems: Improved Detection Using Whole Blood as the Source of Viral RNA

Jack T. Stapleton,1,2,* Donna Klinzman,1 Warren N. Schmidt,1,2 Michael A. Pfaller,3 Ping Wu,1,2,dagger Douglas R. LaBrecque,1,2 Jian-qiu Han,1,2,Dagger Mary Jeanne Perino Phillips,2 Robert Woolson,4 and Beth Alden3

Veterans Administration Medical Center, Iowa City, Iowa 52246,1 and Departments of Internal Medicine,2 Pathology,3 and Preventive Medicine,4 University of Iowa College of Medicine, Iowa City, Iowa 52242

Received 22 September 1998/Returned for modification 9 November 1998/Accepted 30 November 1998

We previously demonstrated that whole blood contains significantly more hepatitis C virus (HCV) RNA than plasma. To validate the whole-blood-based HCV RNA detection method, a prospective comparison of HCV RNA detection in whole blood and plasma from 50 patients with chronic liver disease was undertaken. Whole-blood and plasma aliquots were independently tested for HCV RNA by reverse transcriptase (RT) PCR assay, and plasma was tested by the Roche Amplicor assay. HCV RNA was detected in 35 of 50 (70%) whole-blood samples by RT-PCR but in only 26 of 50 (52%) plasma samples tested by the Amplicor assay (P < 0.01). HCV RNA was detected in 85% of HCV antibody-positive patients by the whole-blood method compared with 74% of plasma samples by the Amplicor method. The five HCV antibody-positive subjects who were negative by whole-blood-based RT-PCR assay were all receiving interferon therapy and had normal transaminases at the time of testing. HCV RNA was detected in 38% of HCV antibody-negative subjects by the whole-blood-based RT-PCR assay compared with 6.25% of these patients by the Amplicor assay (P < 0.05). There were nine samples in which HCV RNA was detected in whole blood but the Amplicor test was negative. Eight of the nine RNAs prepared from these whole-blood samples tested positive in the Amplicor assay, thus confirming the specificity of our results. This study demonstrates that whole-blood-based HCV RNA detection is more sensitive than currently available commercial tests and that whole-blood RNA is suitable for use in commercial assays.

* Corresponding author. Mailing address: University of Iowa Hospitals and Clinics, Department of Internal Medicine, SW 54 GH, 200 Hawkins Dr., UIHC, Iowa City, IA 52242. Phone: (319) 356-3168. Fax: (319) 356-4600. E-mail: jack-stapleton{at}uiowa.edu.

dagger Present address: Shanghai RAAS Blood Product Co., Ltd., Shanghai, People's Republic of China.

Dagger Present address: Shanghai Institute of Biological Products, Shanghai 200052, People's Republic of China.

Journal of Clinical Microbiology, March 1999, p. 484-489, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Forman, M. S., Valsamakis, A. (2004). Increased Sensitivity of the Roche COBAS AMPLICOR HCV Test, Version 2.0, Using Modified Extraction Techniques. J. Mol. Diagn. 6: 225-230 [Abstract] [Full Text]  
  • Williams, C. F., Klinzman, D., Yamashita, T. E., Xiang, J., Polgreen, P. M., Rinaldo, C., Liu, C., Phair, J., Margolick, J. B., Zdunek, D., Hess, G., Stapleton, J. T. (2004). Persistent GB Virus C Infection and Survival in HIV-Infected Men. NEJM 350: 981-990 [Abstract] [Full Text]  
  • Schmidt, W., Stapleton, J. T., Knight, G. B., Agnello, V. (2001). Whole-Blood Hepatitis C Virus RNA Extraction Methods. J. Clin. Microbiol. 39: 3812-3813 [Full Text]  
  • Cook, L., Ross, A. M., Knight, G. B., Agnello, V. (2000). Use of Whole Blood Specimens for Routine Clinical Quantitation of Hepatitis C Virus RNA Does Not Increase Assay Sensitivity. J. Clin. Microbiol. 38: 4326-4331 [Abstract] [Full Text]  
  • Wünschmann, S., Medh, J. D., Klinzmann, D., Schmidt, W. N., Stapleton, J. T. (2000). Characterization of Hepatitis C Virus (HCV) and HCV E2 Interactions with CD81 and the Low-Density Lipoprotein Receptor. J. Virol. 74: 10055-10062 [Abstract] [Full Text]  
  • Xiang, J., Wünschmann, S., Schmidt, W., Shao, J., Stapleton, J. T. (2000). Full-Length GB Virus C (Hepatitis G Virus) RNA Transcripts Are Infectious in Primary CD4-Positive T Cells. J. Virol. 74: 9125-9133 [Abstract] [Full Text]  
  • Oelrichs, R. B., Shrestha, I. L., Anderson, D. A., Deacon, N. J. (2000). The Explosive Human Immunodeficiency Virus Type 1 Epidemic among Injecting Drug Users of Kathmandu, Nepal, Is Caused by a Subtype C Virus of Restricted Genetic Diversity. J. Virol. 74: 1149-1157 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»